205 related articles for article (PubMed ID: 25855796)
1. Higher circulating adiponectin levels are associated with increased risk of atrial fibrillation in older adults.
Macheret F; Bartz TM; Djousse L; Ix JH; Mukamal KJ; Zieman SJ; Siscovick DS; Tracy RP; Heckbert SR; Psaty BM; Kizer JR
Heart; 2015 Sep; 101(17):1368-74. PubMed ID: 25855796
[TBL] [Abstract][Full Text] [Related]
2. The associations of leptin, adiponectin and resistin with incident atrial fibrillation in women.
Ermakov S; Azarbal F; Stefanick ML; LaMonte MJ; Li W; Tharp KM; Martin LW; Nassir R; Salmoirago-Blotcher E; Albert CM; Manson JE; Assimes TL; Hlatky MA; Larson JC; Perez MV
Heart; 2016 Sep; 102(17):1354-62. PubMed ID: 27146694
[TBL] [Abstract][Full Text] [Related]
3. Joint Associations of Obesity and NT-proBNP With the Incidence of Atrial Fibrillation in the ARIC Study.
Almuwaqqat Z; O'Neal WT; Norby FL; Lutsey PL; Selvin E; Soliman EZ; Chen LY; Alonso A
J Am Heart Assoc; 2019 Oct; 8(19):e013294. PubMed ID: 31564186
[TBL] [Abstract][Full Text] [Related]
4. Exploration of pathophysiological pathways for incident atrial fibrillation using a multiplex proteomic chip.
Molvin J; Jujic A; Melander O; Pareek M; Råstam L; Lindblad U; Daka B; Leosdottir M; Nilsson P; Olsen M; Magnusson M
Open Heart; 2020; 7(1):e001190. PubMed ID: 32201587
[TBL] [Abstract][Full Text] [Related]
5. Proteomics and Risk of Atrial Fibrillation in Older Adults (From the Atherosclerosis Risk in Communities [ARIC] Study).
Norby FL; Tang W; Pankow JS; Lutsey PL; Alonso A; Steffen BT; Chen LY; Zhang M; Shippee ND; Ballantyne CM; Boerwinkle E; Coresh J; Folsom AR
Am J Cardiol; 2021 Dec; 161():42-50. PubMed ID: 34794617
[TBL] [Abstract][Full Text] [Related]
6. NT-proBNP is a powerful predictor for incident atrial fibrillation - Validation of a multimarker approach.
Svennberg E; Lindahl B; Berglund L; Eggers KM; Venge P; Zethelius B; Rosenqvist M; Lind L; Hijazi Z
Int J Cardiol; 2016 Nov; 223():74-81. PubMed ID: 27541645
[TBL] [Abstract][Full Text] [Related]
7. B-type natriuretic peptide for incident atrial fibrillation-The Heinz Nixdorf Recall Study.
Kara K; Geisel MH; Möhlenkamp S; Lehmann N; Kälsch H; Bauer M; Neumann T; Dragano N; Moebus S; Jöckel KH; Erbel R; Mahabadi AA
J Cardiol; 2015 Jun; 65(6):453-8. PubMed ID: 25241013
[TBL] [Abstract][Full Text] [Related]
8. Association Between Vascular Cell Adhesion Molecule 1 and Atrial Fibrillation.
Willeit K; Pechlaner R; Willeit P; Skroblin P; Paulweber B; Schernthaner C; Toell T; Egger G; Weger S; Oberhollenzer M; Kedenko L; Iglseder B; Bonora E; Schett G; Mayr M; Willeit J; Kiechl S
JAMA Cardiol; 2017 May; 2(5):516-523. PubMed ID: 28355442
[TBL] [Abstract][Full Text] [Related]
9. Plasma resistin, adiponectin, and risk of incident atrial fibrillation: the Framingham Offspring Study.
Rienstra M; Sun JX; Lubitz SA; Frankel DS; Vasan RS; Levy D; Magnani JW; Sullivan LM; Meigs JB; Ellinor PT; Benjamin EJ
Am Heart J; 2012 Jan; 163(1):119-124.e1. PubMed ID: 22172445
[TBL] [Abstract][Full Text] [Related]
10. B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies.
Sinner MF; Stepas KA; Moser CB; Krijthe BP; Aspelund T; Sotoodehnia N; Fontes JD; Janssens AC; Kronmal RA; Magnani JW; Witteman JC; Chamberlain AM; Lubitz SA; Schnabel RB; Vasan RS; Wang TJ; Agarwal SK; McManus DD; Franco OH; Yin X; Larson MG; Burke GL; Launer LJ; Hofman A; Levy D; Gottdiener JS; Kääb S; Couper D; Harris TB; Astor BC; Ballantyne CM; Hoogeveen RC; Arai AE; Soliman EZ; Ellinor PT; Stricker BH; Gudnason V; Heckbert SR; Pencina MJ; Benjamin EJ; Alonso A
Europace; 2014 Oct; 16(10):1426-33. PubMed ID: 25037055
[TBL] [Abstract][Full Text] [Related]
11. Total and high-molecular-weight adiponectin and risk of coronary heart disease and ischemic stroke in older adults.
Kizer JR; Benkeser D; Arnold AM; Djousse L; Zieman SJ; Mukamal KJ; Tracy RP; Mantzoros CS; Siscovick DS; Gottdiener JS; Ix JH
J Clin Endocrinol Metab; 2013 Jan; 98(1):255-63. PubMed ID: 23162097
[TBL] [Abstract][Full Text] [Related]
12. Amino-terminal B-natriuretic peptide levels and postablation recurrence in hypertensive patients with paroxysmal atrial fibrillation.
Giannopoulos G; Kossyvakis C; Angelidis C; Efremidis M; Panagopoulou V; Letsas K; Bouras G; Vassilikos VP; Goudevenos J; Tousoulis D; Lekakis J; Deftereos S
Heart Rhythm; 2015 Jul; 12(7):1470-5. PubMed ID: 25847478
[TBL] [Abstract][Full Text] [Related]
13. Serum androgens and risk of atrial fibrillation in older men: The Cardiovascular Health Study.
Rosenberg MA; Shores MM; Matsumoto AM; Bůžková P; Lange LA; Kronmal RA; Heckbert SR; Mukamal KJ
Clin Cardiol; 2018 Jun; 41(6):830-836. PubMed ID: 29671886
[TBL] [Abstract][Full Text] [Related]
14. Adiponectin and the risk of new-onset atrial fibrillation: a meta-analysis of prospective cohort studies.
Guo Y; Liu L; Wang J
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31088901
[No Abstract] [Full Text] [Related]
15. Left ventricular shape predicts different types of cardiovascular events in the general population.
Ambale-Venkatesh B; Yoneyama K; Sharma RK; Ohyama Y; Wu CO; Burke GL; Shea S; Gomes AS; Young AA; Bluemke DA; Lima JA
Heart; 2017 Apr; 103(7):499-507. PubMed ID: 27694110
[TBL] [Abstract][Full Text] [Related]
16. N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).
Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Christersson C; Ezekowitz J; Gersh BJ; Hanna M; Hohnloser S; Horowitz J; Huber K; Hylek EM; Lopes RD; McMurray JJ; Granger CB
J Am Coll Cardiol; 2013 Jun; 61(22):2274-84. PubMed ID: 23563134
[TBL] [Abstract][Full Text] [Related]
17. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.
Bansal N; Katz R; Dalrymple L; de Boer I; DeFilippi C; Kestenbaum B; Park M; Sarnak M; Seliger S; Shlipak M
Clin J Am Soc Nephrol; 2015 Feb; 10(2):205-14. PubMed ID: 25605700
[TBL] [Abstract][Full Text] [Related]
18. N-terminal pro B-type natriuretic peptide in systematic screening for atrial fibrillation.
Svennberg E; Henriksson P; Engdahl J; Hijazi Z; Al-Khalili F; Friberg L; Frykman V
Heart; 2017 Aug; 103(16):1271-1277. PubMed ID: 28255099
[TBL] [Abstract][Full Text] [Related]
19. Elevated admission N-terminal pro-brain natriuretic peptide level predicts the development of atrial fibrillation in general surgical intensive care unit patients.
Chokengarmwong N; Yeh DD; Chang Y; Ortiz LA; Kaafarani HMA; Fagenholz P; King DR; DeMoya M; Butler K; Lee J; Velmahos G; Januzzi JL; Lee-Lewandrowski E; Lewandrowski K
J Trauma Acute Care Surg; 2017 Sep; 83(3):485-490. PubMed ID: 28463935
[TBL] [Abstract][Full Text] [Related]
20. Association of sex hormones, aging, and atrial fibrillation in men: the Framingham Heart Study.
Magnani JW; Moser CB; Murabito JM; Sullivan LM; Wang N; Ellinor PT; Vasan RS; Benjamin EJ; Coviello AD
Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):307-12. PubMed ID: 24610804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
